Targeting the mRNA of ‘undruggable’ proteins in the fight against Parkinson’s disease

Researchers at the Scripps Research Institute, Florida, have developed a new method to counteract α-synuclein protein levels by targeting the mRNA that forms them. The strategy unlocks many research doors with potential therapeutic approaches for addressing neurodegenerative diseases.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart